Thermo Fisher Scientific
TMONASDAQ·Health Care
Company Overview
Thermo Fisher Scientific Inc. is an American life science and clinical research company. It is a global supplier of analytical instruments, clinical development solutions, specialty diagnostics, laboratory, pharmaceutical and biotechnology services. Based in Waltham, Massachusetts, Thermo Fisher was formed through the merger of Thermo Electron and Fisher Scientific in 2006. Thermo Fisher Scientific has acquired other reagent, consumable, instrumentation, and service providers, including Life Technologies Corporation (2013), Alfa Aesar (2015), Affymetrix (2016), FEI Company (2016), BD Advanced Bioprocessing (2018), and PPD (2021).
- Industry
- Life Sciences Tools & Services
Financial Summary
- Revenue (TTM)
- $16.96B
- Net Income (TTM)
- $1.33B
- Total Assets
- $97.15B
- Total Debt
- $34.73B
- Total Equity
- $46.73B
- Market Cap
- -
Valuation Metrics
- P/E Ratio
- -
- P/B Ratio
- -
- Profit Margin
- 7.84%
- ROE
- 2.85%
- ROA
- 1.37%
- Dividend Yield
- -